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Objectives: Discovery of Quorum Sensing (QS) offers attractive strategies in
Pseudomonas aeruginosa infection control, interfering with this bacteria-to-bacteria
communication system. Molecules, such as natural furanone, have been described
as QS-inhibitors given their similarity to the natural QS-autoinducers called N -
acyl-homoserine lactones (HSL): C4-HSL and 3-oxo-C12-HSL. Besides their role
in bacterial virulence regulation, HSL also have an immuno-modulatory activity.
These properties have been especially demonstrated with 3-oxo-C12-HSL, but
never with C4-HSL. The goal of this study was to examine the ability of 3-oxo-
C12-HSL and C4-HSL to induce pro-inﬂammatory cytokine production in human
monocyte derived macrophages, and the potent modiﬁcation of the cell response
in the presence of QS-inhibitors: furanone and N-pyrimidyl butanamide (C11), an
original compound designed in our laboratory.
Methods: Among eight blood donors tested, both P. aeruginosa HSLs were found
to induce IL-6 production, and seem to have cumulative pro-inﬂammatory effect
when added together. These data suggest that 3-oxo-C12-HSL, but also C4-HSL,
may possess immuno-modulatory activity, playing a role in P. aeruginosa infection
pathophysiology. Furanone and C11 do not show similar effects and their association
with HSL induce various modiﬁcations in the IL-6 production in human monocyte
derived macrophages.
Conclusion: To improve these results about QS-inhibitors immuno-modulatory
properties, we need to pursue our investigations using LPS-stimulated human
macrophages, various timing of reagent associations and tests in normal and cystic
ﬁbrosis bronchial epithelial cells.
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Objectives: Oral treatment with pathogen-speciﬁc IgY antibodies poses a promising
complement to antibiotics in averting the devastating chronic lung infections with
Pseudomonas aeruginosa (PA) in Cystic Fibrosis (CF). Anti-PA IgY antibodies
augments the PMN-mediated bacterial killing in vitro, indicating a faster bacterial
clearance of pathogens in the airways. The present study aimed at exploring
whether IgY-mediated bacterial aggregation improves the internalization of bacteria
in PMNs.
Methods: Anti-PA IgY solution was obtained from ImmunSystem AB (Sweden).
Pseudomonas aeruginosa PAO1 strain was grown in LB broth. Stationary phase
organisms were obtained from overnight cultures (ON).
Neutrophil isolation: PMNs were isolated from whole human blood.
Bactericidal assay: Measuring the loss of bacterial viability over time by mixing
(non)opsonized bacteria and PMNs and plating diluted samples overnight followed
by colony counting.
Immunoﬂuorescence microscopy: PAO1 was mixed with S-IgY and secondary
TexasRed-conjugated rabbit anti-chicken IgG followed by smearing the solution
on microscope slide. Immunoﬂuorescent micrographs of specimens were obtained
using a confocal laser scanning microscope (CLSM) after DAPI stain.
PMN mediated phagocytosis of PAO1 was visualized and captured by CSLM
imaging. ON of ﬂuorescent PAO1 ([GFP]) was mixed with S-IgY or PBS and
allowed to aggregate prior to addition of PMNs.
Conclusion: Anti-Pseudomonas aeruginosa IgY antibodies improves the bacterial
internalization in PMNs and subsequent bacterial killing in vitro by conferring
bacterial aggregation, suggesting a mode of action to the observed clinical impact
of oral IgY treatment.
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Objectives: Burkholderia cepacia complex (BCC) bacteria have gained notoriety as
dangerous pathogens in cystic ﬁbrosis (CF). Studies on their virulence mechanisms
have proved the exceptional adaptation ability of these bacteria, suggesting an
interplay with host immune determinants. Usually, dendritic cells (DCs) play an
essential role in immunity against bacteria by phagocytosing and eliciting adaptive
immune responses. However, several pathogens become able to subvert normal
antimicrobial immune responses by changing DCs regular functions, thus avoiding
T cell responses. Information regarding the interaction of BCC bacteria and DCs
is still scarce. Therefore this work aimed to elucidate more this issue.
Methods: We studied 4 clonal variants of B. cenocepacia, isolated from a CF
patient, during the progression of the infection [1], and investigated if there were
differences between the 4 isolates in their ability to modulate DCs functions.
Conclusion: The obtained results revealed that the clonal variant isolated more
recently, which exhibits the highest virulent phenotype, is better internalized by DCs
giving rise to higher levels of inﬂammatory cytokines expression. Interestingly, this
isolate was also the one that lead to an higher suppression of DCs maturation, shown
by a downregulation of the maturation markers expression, specially HLA-DR.
So far our ﬁndings suggest that a mechanism of immunological evasion involving
DCs, should be considered a relevant factor for the success of B. cenocepacia
infection.
Reference(s)
[1] Coutinho et al., 2011, Infection and Immunity, 79(7):2950–2960.
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Objectives: Basophil Activation Test (BAT) is a novel ﬂow cytometric method
that enables the assessment of IgE mediated hypersensitivity reactions to speciﬁc
antigens. Being such a reaction, Allergic Brochopulmonary Aspergillosis (ABPA),
may represent a disease for which BAT could be applied. The purpose of this study
was to investigate the role of BAT using Aspergillus fumigatus extract antigens, in
the diagnosis of ABPA in the Cystic Fibrosis setting.
Methods: Starting as of 09/2005, BAT has been applied to 5 normal controls and to
59 samples of 49 CF patients (3−23 years old), of which 10 without signs of ABPA,
13 with deﬁnite ABPA under corticosteroid treatment, 7 with deﬁnite ABPA prior
to corticosteroid administration, 20 with probable ABPA diagnosis and 9 patients
in whom ABPA was resolved. BAT results (percentage of basophils with CD203c
and CD63 up regulation) were correlated to the patients’ clinical course within 1.5
to 7 years and with ABPA diagnosis using consensus 2003 criteria.
Conclusion: BAT results were signiﬁcantly correlated with ABPA diagnosis and
SPT results. CD203c up regulation results were also signiﬁcantly correlated with
IgE serum levels. BAT was normal in all controls and CF patients without ABPA.
Among CF patients with probable ABPA, there was a statistically signiﬁcant
temporal correlation of BAT levels with ﬁnal development of the disease, by cox
regression. As a conclusion, BAT was found to be predictive of ABPA development
and could be a candidate additional criterion to ABPA diagnosis.
